- About ASF
- What is Autism?
- How Common is Autism?
- Early Signs of Autism
- Autism Diagnosis
- Following a Diagnosis
- Treatment Options
- Beware of Non-Evidence-Based Treatments
- Autism and Vaccines
- Autism Science
- Quick Facts About Autism
- What We Fund
- Autism Sisters Project
- Baby Siblings Research Consortium
- Resources for Grantees
- Funding Calendar
- ASF Funded Research
- ASF Supported Findings
- Apply for a Fellowship
- Apply for a Research Accelerator Grant
- Apply for an Undergraduate Summer Research Grant
- Apply for INSAR Annual Meeting Travel Grant
- Get Involved
- Day of Learning
- Research Recap of 2017
- Contact Us
Joon An, PhD | University of California, San Francisco
Mentor: Stephan Sanders, PhD
Determining the nature and function of the SCN2A mutation in ASD
SCN2A is a gene that encodes a sodium channel that is critical for communication between brain cells, and has been shown to be important for both ASD and infantile seizures. This study will first use an animal model to examine how disruption of SCN2A function at different times in development affects other genes known to play a role in autism. Dr. An will also work with collaborators at UCSF to compare the behavioral and medical features of people with this mutation and autism compared to those without an autism diagnosis. This will help identify the more precise role of this mutation in autism. Eventually, this model could be used to test therapies that might improve symptoms in both people with the SCN2 mutation and those with other causes of ASD.
This fellowship is supported through a partnership between the Autism Science Foundation and the Families SCN2A Foundation.
Laurel Joy Gabard-Durnam, PhD | Harvard University
Mentor: Charles Nelson, MD, PhD
Examining brain function during critical periods of development in ASD
There are particular periods in brain development that are more critical to the development of autism spectrum disorders. These critical periods represent times when the brain is particularly plastic. In order to understand these critical periods in neurodevelopmental disorders, Dr. Gabard-Durnam will analyze measures of brain activity and function at multiple times across development in children with autism and Rett Syndrome, and compare them to brainwave activity measurements from those who are typically-developing. This includes periods of regression in girls with Rett syndrome. This research will help inform the timing and biological targets for effective interventions and improve the quality of life for individuals with neurodevelopmental disorders and ASD.
This fellowship is supported through a partnership between the Autism Science Foundation and the Rett Syndrome Research Trust.
Aaron Gordon, PhD | University of California, Los Angeles
Mentor: Daniel Geschwind, MD, PhD
Identifying the converging genetic pathways across different forms of ASD
Due to advances in genetic technologies, more genetic mutations that lead to ASD are being identified. These newly-discovered, rare mutations are most often associated with higher levels of cognitive impairment and medical comorbidities. Little is known about how these genes affect brain development, how they interact with other autism genes, or how they lead to different outcomes in autism. This study will use stem cells to generate neurons from individuals with these rare genetic mutations to compare them to individuals with autism who don’t have these new-found mutations. This will allow scientists to investigate the development of brain cells and see commonalities and differences across the different forms of autism and enable the development of better therapies for all people with an autism diagnosis.
Whitney Guthrie, PhD | Children’s Hospital of Philadelphia
Mentor: Robert Schultz, PhD
Developing a novel method for early screening of autism using electronic medical records
Although most pediatricians agree that screening for ASD at 18 and 24 months of age is needed, it is clear that additional screening methods are necessary in order to identify every child with ASD as early as possible. This research will utilize electronic health records of more than 75,000 children at 9, 18, and 30 months of age, both with and without a later diagnosis of autism, to determine whether critical information on development, already available in the medical records, could help inform pediatricians of the early signs and symptoms of ASD before formal screening would occur. This could eventually lead to a clinical tool embedded in health records that would alert providers to a child’s risk for ASD, and allow clinicians to better evaluate children with these early developmental risk indicators.
Christine Ochoa-Escamilla, PhD | University of Texas Southwestern Medical Center
Mentor: Peter Tsai, MD, PhD
Understanding the genetic influence of brain circuitry in ASD
Through studying the brains of people with autism, scientists have discovered a decrease in the number of Purkinje Cells, which are a type of neuron in the cerebellum. So far, animal models have not been able to selectively turn these particular neurons on and off to understand how they connect to other brain areas, like the cortex, to contribute to ASD. This study will utilize newer genomic technologies to deactivate Purkinje Cells in mice with a gene mutation associated with ASD. This will identify specific brain connections that are relevant for ASD and accelerate the design of targeted therapies based on particular brain circuits. Dr. Ochoa-Escamilla will continue her science training at UTSW by expanding on a project she began through an ASF fellowship last year.
Amy Ahn | University of Miami
Mentor: Daniel Messinger, PhD
Automating and accelerating the autism diagnostic process
New technology and advanced methodology have given scientists tools to better understand and measure the symptoms of autism. This may eventually lead to automated, clinical evaluations that would speed up the diagnostic process. This study will use a head-mounted camera to track early social behaviors during a structured evaluation for autism with a clinician. Researchers will evaluate an equal number of three-year-old boys and girls to determine if there are sex differences in these early social behaviors and social affect severity. This video and objective measurement will provide a way to measure and quantify ASD symptoms that may be useful for both categorization of different features of autism as well as developing gender-specific referral guidelines.
Cara Keifer, MA | Stony Brook University
Mentor: Matt Lerner, PhD
Explaining how the ASD brain works during social interactions
Youth with autism interpret, understand, and respond to the world differently than adults. This is especially evident in social situations when people are presented with various social cues. This project will look at brain activity before, during, and after the presentation of different social cues to better understand how and why the brains of people with autism work differently. The goal is to help clinicians understand how small differences in the way a person’s brain responds to social interaction could contribute to large differences in the way they interact with other people. Additionally, identifying the specific stages at which individuals with ASD demonstrate differences in social information processing will enable scientists to tailor treatments to have the biggest impact on behavior.
Julia Yurkovic | Indiana University
Mentor: Daniel Kennedy, PhD
Evaluating attentional deficits in ASD during real life situations
In order to better understand the attentional problems of those with autism, which are usually most apparent during naturalistic, unconstrained real-world interactions, researchers in this study will use a wearable eye tracking device to monitor attention in toddlers with autism. Specifically, researchers will be able to look at where the eyes are pointed when toddlers play with each other, with toys, and with their parents. Scientists will also be able to determine how toddlers coordinate their attention with their parents’. The results will improve targeted attention-based early intervention programs for ASD.
Undergraduate Summer Research Grants:
Ethan Gahr | Seattle Children’s Hospital
Mentor: Sara Jane Webb, PhD
Ethan will build upon a large NIH study examining why more males than females are diagnosed with autism. He will study brain activity in adults with autism and their undiagnosed siblings, focusing on undiagnosed sisters who may carry genetic liability for ASD but, for some reason, do not show clinical symptoms. His findings may help scientists understand why females are often underdiagnosed, and inform the development of more targeted interventions for females with ASD.
Evan Suzman | Vanderbilt University
Mentor: Tiffany Woynaroski, PhD
Evan will study infants known as “baby siblings” who have a high probability of an autism diagnosis because they have an older sibling with autism. Using this design, the group at Vanderbilt will look at early sensory features to determine how they relate to later social communication and language deficits. These findings may help shape early intervention techniques in infants with sensory issues.
Christina Layton | Seaver Autism Center at the Icahn School of Medicine, Mount Sinai
Mentor: Jennifer Foss-Feig, PhD
Christina will spend the summer at the Seaver Autism Center examining biological pathways in the brain that coordinate sensory information from the eyes, ears, and brain. Specifically, she will use brain activity measurements to see how disruptions in these pathways affect visual and auditory processing in people with autism. The results will identify how these biological measures explain symptom severity in people with autism, and may be used to complement behavioral measures to improve diagnosis of ASD.
Ryan Risgaard | University of Wisconsin, Madison
Mentor: Xinyu Zhao, PhD
Fragile X Syndrome is caused by mutation of the FMR1 gene that results in a reduction of FMRP protein. Low FMRP levels can cause cognitive disability, anxiety, hyperactivity, and autism. Ryan will be working with Dr. Zhao to examine new molecules that, when applied to certain cells, can reignite production of the FMRP protein. This project will provide critical information on new compounds that may ultimately be used to treat core symptoms of ASD.